Skip to main content
Livermore
Livermore
ZHEN

Denali Therapeutics Inc.

DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001714899

In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Denali Therapeutics Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of DNLI: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders2032217+16
Shares123.9M13.4M126.8M+16.3M (+14.7%)
Value$2.88B$311.1M$3.69B+$1.13B (+43.9%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held Denali Therapeutics Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to DNLI in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.13,788,517$401.7M0.01%
Siren, L.L.C.834,028$24.3M1.22%
Nomura Asset Management Co Ltd65,033$1.89M0.01%
Bank of Montreal42,259$1.24M0.00%
Intech Investment Management LLC29,543$860.6K0.01%
Trexquant Investment LP24,534$714.7K0.01%
Options Solutions, LLC17,611$513.0K0.25%
HRT Financial LP16,943$493.0K0.00%
AQR Capital Management LLC16,018$466.6K0.00%
Cowen and Company, LLC15,800$460.3K0.02%
Bellevue Group AG15,700$457.3K0.01%
VELA Investment Management, LLC15,635$455.4K0.16%
Graham Capital Management, L.P.11,765$342.7K0.01%
Pitcairn Co11,259$328.0K0.02%
nVerses Capital, LLC9,900$288.4K0.13%
Integrated Advisors Network LLC9,710$282.9K0.01%
Mackenzie Financial Corp8,256$240.5K0.00%
Xponance, Inc.8,135$237.0K0.00%
Life Line Wealth Management LLC7,812$227.6K0.08%
Breakwater Capital Group7,642$222.6K0.04%
Colony Group, LLC7,597$221.3K0.00%
Ameriprise Financial Inc7,400$215.6K0.00%
Acadian Asset Management LLC2,749$80.0K0.00%
Quest Partners LLC2,512$73.2K0.01%
Catalyst Funds Management Pty Ltd2,000$58.3K0.01%
Group One Trading, L.P.1,691$49.3K0.00%
Oarsman Capital, Inc.500$14.6K0.00%
Umb Bank N A382$11.1K0.00%
Sterling Capital Management LLC257$7.49K0.00%
Meeder Asset Management Inc159$4.63K0.00%
Bessemer Group Inc110$3.00K0.00%
Capital Performance Advisors LLP63$1.83K0.00%
Point72 (DIFC) Ltd55$1.61K0.00%
AdvisorNet Financial, Inc40$1.17K0.00%
National Bank of Canada34$9900.00%
Bokf, NA18$5080.00%
Hemington Wealth Management3$00.00%

Sold out (21)

Institutions that held Denali Therapeutics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of DNLI in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Takeda Pharmaceutical Co Ltd4,214,559$97.9M
Artal Group S.A.502,899$11.7M
Vestal Point Capital, LP500,000$11.6M
Integral Health Asset Management, LLC325,000$7.55M
Schonfeld Strategic Advisors LLC163,074$3.79M
PDT Partners, LLC158,384$3.68M
Tudor Investment Corp Et Al58,523$1.36M
Woodline Partners LP56,554$1.31M
Voloridge Investment Management, LLC54,056$1.26M
Eisler Capital (US) LLC35,861$832.7K
D. E. Shaw & Co., Inc.29,721$690.1K
Hamilton Lane Advisors LLC25,657$595.8K
Fox Run Management, L.L.C.24,390$566.3K
Engineers Gate Manager LP11,130$258.4K
Prelude Capital Management, LLC10,343$240.2K
Quarry LP6,500$150.9K
Pacer Advisors, Inc.862$20.0K
Allworth Financial LP64$1.37K
Valley National Advisers Inc50$1.00K
Innealta Capital, LLC30$696
CIBC Private Wealth Group, LLC1$21

Not filed for Q3 2024 yet (2)

Institutions that held Denali Therapeutics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DNLI in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.13,174,562$305.9M
Susquehanna Fundamental Investments, LLC222,917$5.18M